Tag Archives: gw pharmaceuticals

GW Pharmaceuticals’ CEO talks Epidiolex, future of cannabidiol medicine

This is a make-or-break spring for GW Pharmaceuticals and its billion-dollar investment in a cannabidiol-based drug. The London-based firm aims to develop the first FDA-approved medicine from plant-derived cannabis compounds. The U.S. Food and Drug Administration could decide as early as

CBD could be in the fast lane to Colorado pharmacies

Cannabidiol is available in Colorado health food stores, but the state’s marijuana laws prevent the cannabis compound from being sold in pharmacies. A bill moving through the Statehouse would open the doors for GW Pharmaceuticals’ CBD-centric Epidiolex drug to be

CBD, TBD: Cannabinoids on local grocery shelves, but for how long?

Published: Dec 29, 2017, 2:51 pm • Updated: Dec 29, 2017, 4:28 pm By Alicia Wallace, The Cannabist Staff Bottles of hemp-derived oils sit behind glass, under lock and key, at Alfalfa’s natural foods store in Boulder, Colo. Some 2,000

“A significant event”: CBD-based pharma drug Epidiolex presented to FDA for approval

Published: Nov 3, 2017, 4:49 pm • Updated: Nov 3, 2017, 4:56 pm By Alicia Wallace, The Cannabist Staff A CBD-based pharmaceutical drug in development is one more step closer to potential FDA approval. Earlier this week, London-based GW Pharmaceuticals

Race for CBD medication breakthrough: Is pharma firm’s boon the hemp industry’s doom?

Published: Oct 6, 2017, 8:16 am • Updated: Oct 6, 2017, 8:22 am By Alicia Wallace, The Cannabist Staff Cannabidiol is a non-psychoactive cannabis compound touted for its medicinal promise — but marijuana- and hemp-derived extracts rich in CBD and

Skip to toolbar